MUPHORAN

This brand name is authorized in Austria, Australia, Brazil, France

Active ingredients

The drug MUPHORAN contains one active pharmaceutical ingredient (API):

1 Fotemustine UNII GQ7JL9P5I2 - FOTEMUSTINE

Fotemustine is a chloroethylating nitrosourea with antineoplastic activity. Fotemustine alkylates guanine by forming chloroethyl adducts at the 6 position of guanine, resulting in N1-guanine and N3-cytosine cross linkages, inhibition of DNA synthesis, cell cycle arrest, and finally apoptosis. This agent is lipophilic and crosses the blood-brain barrier. Read about Fotemustine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01AD05	Fotemustine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AD Nitrosoureas
Discover more medicines within L01AD05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 4437M, 7245H
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 531300901153318
Country: FR	Base de données publique des médicaments	Identifier(s): 63675185